Drugs Acting on Fetal Growth Abnormalities: A Comprehensive Overview
Abstract
Fetal growth abnormalities pose a challenge on a significant manner to maternal and child health, influencing well_ being of both mother and baby. Many factors such as environmental, genetic and maternal conditions, can correlate with deviations particularly in fetal growth. Folic acid is a critical B_ vitamin that plays an important role in fetal development particularly in the early stages of pregnancy. Deficiencies of folic acid can result in neural tube defects as well as growth abnormalities. Growth hormone therapy activates skeletal and organ growth particularly regarding the development of fetus. Low_ dose aspirin helps in stopping pre_ eclampsia and fetal growth. Pre eclampsia , a condition manifested by high blood pressure, can result in restricted blood flow to the fetus, influencing it's growth. Corticosteroids namely betamethasone, are used if preterm birth is imminent. These drugs assist in enhancing fetal lung maturation and decrease the risk of respiratory distress syndrome ( RDS ) , frequently associated with preterm births. Antibiotics may be preferred to treat infections, stopping their potential impact on the developing fetus Gestational diabetes plays an important role regarding fetal over growth ( macrosimia ). An administration of magnesium sulfate is required especially in cases of preterm labor to provide protection to the fetal brain especially from potential damage. It is essentially is seen in Cerebral palsy. Finally it is concluded that drugs play a critical role especially in managing These abnormalities.
Full Text:
PDFReferences
Romo A, Carceller R, Tobajas J. Intrauterine growth retardation (IUGR): epidemiology and etiology. Pediatr Endocrinol Rev. 2009 Feb;6 Suppl 3:332-6. [PubMed]
Sharma D, Shastri S, Sharma P. Intrauterine Growth Restriction: Antenatal and Postnatal Aspects. Clin Med Insights Pediatr. 2016;10:67-83. [PMC free article] [PubMed]
Lee PA, Chernausek SD, Hokken-Koelega AC, Czernichow P., International Small for Gestational Age Advisory Board. International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001. Pediatrics. 2003 Jun;111(6 Pt 1):1253-61. [PubMed]
Faraci M, Renda E, Monte S, Di Prima FA, Valenti O, De Domenico R, Giorgio E, Hyseni E. Fetal growth restriction: current perspectives. J Prenat Med. 2011 Apr;5(2):31-3. [PMC free article] [PubMed]
Longo S, Borghesi A, Tzialla C, Stronati M. IUGR and infections. Early Hum Dev. 2014 Mar;90 Suppl 1:S42-4. [PubMed]
Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag. 2011;7:467-74. [PMC free article] [PubMed]
Rotshenker-Olshinka K, Michaeli J, Srebnik N, Terlezky S, Schreiber L, Farkash R, Grisaru Granovsky S. Recurrent intrauterine growth restriction: characteristic placental histopathological features and association with prenatal vascular Doppler. Arch Gynecol Obstet. 2019 Dec;300(6):1583-1589. [PubMed]
Morse K, Williams A, Gardosi J. Fetal growth screening by fundal height measurement. Best Pract Res Clin Obstet Gynaecol. 2009 Dec;23(6):809-18. [PubMed]
Marsico C, Kimberlin DW. Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment. Ital J Pediatr. 2017 Apr 17;43(1):38. [PMC free article] [PubMed]
Witters G, Van Robays J, Willekes C, Coumans A, Peeters H, Gyselaers W, Fryns JP. Trisomy 13, 18, 21, Triploidy and Turner syndrome: the 5T's. Look at the hands. Facts Views Vis Obgyn. 2011;3(1):15-21. [PMC free article] [PubMed]
McCowan LM, Figueras F, Anderson NH. Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy. Am J Obstet Gynecol. 2018 Feb;218(2S):S855-S868. [PubMed]
Committee Opinion No 700: Methods for Estimating the Due Date. Obstet Gynecol. 2017 May;129(5):e150-e154. [PubMed]
Hasmasanu MG, Bolboaca SD, Baizat MI, Drugan TC, Zaharie GC. Neonatal short-term outcomes in infants with intrauterine growth restriction. Saudi Med J. 2015 Aug;36(8):947-53. [PMC free article] [PubMed]
Valsamakis G, Kanaka-Gantenbein C, Malamitsi-Puchner A, Mastorakos G. Causes of intrauterine growth restriction and the postnatal development of the metabolic syndrome. Ann N Y Acad Sci. 2006 Dec;1092:138-47. [PubMed]
Suzuki K, Sato M, Zheng W, Shinohara R, Yokomichi H, Yamagata Z. Effect of maternal smoking cessation before and during early pregnancy on fetal and childhood growth. J Epidemiol. 2014;24(1):60-6. [PMC free article] [PubMed]
Refbacks
- There are currently no refbacks.